HyunJung KO

Hematologic oncology specialist - Mar. 2023 - May. 2025

• Worked with other health care professionals to plan, monitor, review, or evaluate the effectiveness of medications for those who are using anticancer drugs.
• Conducted medication counseling on anticancer drugs for cancer patients, especially those with hematologic cancers, and undergoing Hematopoietic Stem Cell Transplantation.
• Delivered scientific updates on recently approved oncology agents and treatment protocols to other healthcare professionals.
• Biweekly gave a lecture to cancer patients on "Supportive Medications to Reduce Side Effects of Anticancer Drugs."
• Educated intern pharmacists and assisted with writing research papers.
• Educated pharmacy students about chemotherapeutic approaches for hematologic malignancies.

Regional Pharmacovigilance Center - Mar. 2020 - Dec. 2020

• Collected, analyzed, and evaluated adverse drug reactions from local hospitals, clinics, pharmacies, patients, and consumers.
• Reported adverse drug reactions to KIDS (Korea Institute of Drug Safety and Risk Management) through KAERS (The Korea Adverse Event Reporting System).
• Gave various information to the health care professionals or patients related to drug safety.

Intern pharmacist - Mar. 2019 - Feb. 2020

• Trained as a clinical pharmacist.
• Dispensed medications, and provided comprehensive pharmaceutical care in various departments.
• Participated in the NST (Nutritional Support Team): provided pharmaceutical options and nutritional support medication for critically ill patients.
• Patient consult: anticancer drugs, immunosuppressants, warfarin, NOACs, inhaler, etc.
• Conducted a study and published it.